Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Council authorizes concurrent processing for Amgen’s proposed R&D center at Thousand Oaks headquarters
Summary
The council voted 5-0 to allow Amgen to pursue concurrent processing of a specific-plan amendment and development entitlements for a new research-and-development building (Building 50) at its Thousand Oaks campus; Amgen indicated an investment of more than $500 million.
The Thousand Oaks City Council on Oct. 21 unanimously approved a resolution allowing Amgen to pursue concurrent processing of a specific plan amendment and the entitlements needed to develop a new research and development building at its global headquarters in Thousand Oaks.
Staff told the council the request would align the Amgen specific plan (adopted 1994) with the city’s Thousand Oaks 2045 general plan land-use designations, which allow higher building heights in parts of the campus. Senior planner Ian Holt said concurrent processing…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
